Sexually transmitted diseases spread through sexual contact. The cause of these diseases may be bacterial, fungal, viral or protozoa infections. The major types of these diseases include Chlamydia, herpes, human papillomavirus (HPV), Gonorrhea, Syphilis, Trichomoniasis and HIV. Testing of STDs include single infection test or it may include number of tests for range of infections. The different tests include diagnostic test, screening test, contact tracing and epidemiological surveillance. These tests are delivered in the laboratories or at the Point-of-Care (POC). A pin-point analysis of the global market for STDs diagnosis focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities. The competitive landscape section focuses on key leaders within the global market for STDs diagnosis and their major growth strategies. A deep-dive assessment of segments identifies potential segments, which would act as a guide for strategists.
Untreated STDs such as Chlamydia, develop pelvic inflammatory disease among woman, which may further lead to infertility. Majority of the cervical cancers in woman originates from HPV infections and contributes to one of the leading causes of death due to cervical cancer. Globally, high incidence of STDs is the prime driver for this market. Additionally, government induced national screening programs and favorable reimbursement strategies heighten the market growth. Despite of diagnostic testing availability, the global STD testing market finds impediments due to the stigma associated with the testing. Also, hurdles and setbacks are witnessed in the growth of STD testing market due to critical regulatory compliance and widespread diseases in remote areas. Laboratory testing is the reliable method of diagnosis and it could be benefited by the national screening programs in the respective regions. Asia-pacific market provides the niche opportunity for POC testing due to government support and rising healthcare awareness.
Global Market for STDs Diagnosis by Type
The global market for STD diagnosis is segmented based on STD types and include Gonorrhea testing, Human Papilloma Virus (HPV) testing, Chlamydia testing, Chancroid testing, Herpes Simplex Virus (HSV) testing, P&S Syphilis testing & Human Immunodeficiency Virus (HIV) testing. Chlamydia, P&S Syphilis and Gonorrhea have high prevalence, globally. Majority of the cervical cancer related deaths occurs due to HPV infection. Undiagnosed and untreated Syphilis is the prime reason for Congenital Syphilis and lead to preterm labor associated with many complications.
Global Market for STDs Diagnosis by Location
On the basis of location, the global market for STDs diagnosis is categorized into Point-Of-Care (POC) Testing and Laboratory Testing. POC tests do not identify all STDs and many of these methods don’t follow the standard regulatory norms. Hence, laboratory methods are highly significant and reliable.
Global Market for STDs Diagnosis by Geography
Geographically, global market for STD diagnosis is segmented into North America, Europe, Asia-Pacific and LAMEA. North America and Europe has high prevalence of Chlamydia, P&S Syphilis and Gonorrhea and holds the largest share for testing of these infections. Chancroid is almost non-existent in developed regions. Asia-Pacific dominates the market for the testing of HIV, Chancroid and HSV.
The key players within global market for STD diagnosis include Becton, Dickinson, Roche Diagnostics, Biomerieux SA, Gen-Probe Inc., Beckman Coulter, Inc., and Alere. STD testing market has few market players and most of them focus on developing new testing methods for diagnosis of range of STDs. Development of accurate and reliable method that would comply with regulatory guidelines is the major opportunity for market players.
High Level Analysis
A comprehensive analysis of the global market for STD diagnosis provides an overview of the market and its key concerns. The market dynamics section covers market drivers, restraints and opportunities within the global market for STD diagnosis and helps in simplifying market behavior. The market is segmented in order to provide information about niche market areas and assists in identifying potential segments. Porter’s Five Forces analysis enables the determination of profitable markets. Suppliers of this market have high bargaining power due to their limited number in comparison with large pool of population suffering from STDs. National screening programs and government initiatives have supported new players to enter the market, whereas critical regulatory compliance limits their entry into the market. Due to this fact, the threat from new entrants is moderate. Industrial rivalry is moderate due to few market players, which would become intense in the near future due to government support programs for STD testing.
- This report offers the following benefits in particular:
- In-depth coverage of the global market for STD diagnosis including drivers, restraints and opportunities would help professionals better understand market behavior
- Pin-point analysis of geographic segments helps to identify opportunities for growth within the global market for STD diagnosis
- Porter’s Five Forces analysis examines the competitive structure of the global market for STD diagnosis and would assist market strategists
- Detailed study of the strategies of key leaders, partnerships and acquisitions in the global market for STD diagnosis would be informative for professionals in the corporate sector
- The market estimates provided in the report would be informative to market players to define their future strategies
STDs Diagnosis Market Report Highlights
By DISEASE TYPE
By LOCATION OF DIAGNOSIS
By DEVICE TYPE
Key Market Players
DANAHER CORPORATION, AFFYMETRIX, INC., CEPHEID, INC., ABBOTT LABORATORIES, DIASORIN S.P.A., HOLOGIC, INC., ALERE INC., BIOMÉRIEUX SA, F. HOFFMANN-LA ROCHE AG, BECTON DICKINSON & COMPANY